MedPath

AOP Orphan Pharmaceuticals GmbH

AOP Orphan Pharmaceuticals GmbH logo
🇦🇹Austria
Ownership
Private
Established
1996-01-01
Employees
51
Market Cap
-
Website
http://www.aoporphan.com

Clinical Trials

9

Active:5
Completed:0

Trial Phases

1 Phases

Phase 1:8

Drug Approvals

8

EMA:3
CIMA_AEMPS:3
SFDA:2

Drug Approvals

Sugammadex Amomed

Authorization Status
Authorised
Approval Date
Jan 10, 2023
EMA

Sugammadex Amomed

Authorization Status
Authorised
Approval Date
Jan 10, 2023
EMA

Besremi

Authorization Status
Authorised
Approval Date
Feb 15, 2019
EMA

Clinical Trials

Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials

Phase 1
8 (88.9%)
1 (11.1%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.